Number of Zofran Birth Defects Lawsuits Continue To Rise Alleging Cleft Lips and Heart Defects

   

Zofran-birth-defects-lawsuit-lawyer-attorney-9Ten Zofran birth defects lawsuits that allege newborns exposed to the anti-nausea drug suffer birth defects were added to the Zofran litigation over the past month. There are now 270 Zofran birth defects complaints in the multidistrict litigation (MDL), up from 260 in June. The Zofran lawsuits accuse Zofran’s maker, GlaxoSmithKline, of improperly marketing the drug as a treatment for morning sickness in pregnant women but failing to disclose that the drug allegedly causes cleft palate, cleft lip, heart defects and other birth defects. (In Re: Zofran Birth Defects Lawsuit Litigation – MDL No. 2657)

“The rising number of lawsuit filed against the makers of Zofran indicates that families are seeking justice for their children who have suffered severe injuries because of their exposure to Zofran, and we will continue to represent their best interested thought this process.” says Dr. François Blaudeau, co-founder of Southern Med Law. As both an attorney and a practicing obstetrician/gynecologist, Dr. Blaudeau possesses unique insight into the various legal and medical issues at the center of Zofran birth defects cases such as those pending in the U.S. District Court, District of Massachusetts.

Southern Med Law is currently evaluating potential Zofran birth defects lawsuits on behalf of families who believe their child was born with a birth defect due to this medication. To learn more about the litigation involving Zofran and birth defects, please contact the Firm as soon as possible. You can arrange for a free, no obligation Zofran lawsuit review by 205-547-5525 or you can visit www.southernmedlaw for more information and to fill out a contact form.

Zofran birth defects lawsuits were consolidated in October for coordinated pretrial proceedings. Recently, U.S. District Judge F. Dennis Saylor IV, who is managing the Zofran litigation, made it easier for plaintiffs to file lawsuits into the MDL. A Master Complaint with common allegations about Zofran and a Short Form for plaintiffs were recently created. Plaintiffs will be able to choose allegations from the Master Complaint to include in their Short Form complaints. Plaintiffs may also add their personal details about Zofran to the Short Form complaints. (In Re: Zofran (Ondansetron) Products Liability Litigation – MDL No. 2657)

Zofran (ondansetron) is an antiemetic drug approved by the U.S. Food and Drug Administration (FDA) to treat nausea and vomiting related to chemotherapy and radiation, and when it occurs after surgery. Plaintiffs in the Zofran MDL maintain that the FDA has not approved Zofran to treat morning sickness, which includes nausea and vomiting, in expectant mothers. Yet, GlaxoSmithKline promoted Zofran for that purpose. Plaintiffs also claim GlaxoSmithKline knew about Zofran’s harm to an unborn fetus because animal studies from the 1980s indicated Zofran’s active ingredient could cross the placental barrier and reach the developing fetus. (In Re: Zofran (Ondansetron) Products Liability Litigation – MDL No. 2657)

GlaxoSmithKline came under investigation for its marketing of certain drugs, including Zofran, and for its alleged false price reporting practices. In July 2012, GlaxoSmithKline reached an agreement with the U.S. Department of Justice to plead guilty and pay $3 billion to resolve criminal charges and civil liabilities on various claims, including illegally promoting Zofran to doctors and their patients as a treatment for morning sickness. The justice department said this was the largest health care fraud settlement in U.S. history.
[justice.gov/opa/pr/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report, DOJ, July 2, 2012]

About Southern Med Law And Filing A Zofran Birth Defects Lawsuit

Southern Med Law is an experienced law firm providing legal representation individuals across the country who have been victims of negligent personal injuries, medical malpractice, dangerous drugs, faulty medical devices and defective products. Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.

Contact:
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525

Fax: 205-547-5526
francois@southernmedlaw.com

Home


Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article. Bookmark the permalink.